NY Times Corrects Gina Kolata Re: Alzheimer’s
Five weeks after publishing a grossly dis-informative front-page report by Gina Kolata about Alzheimer’s research,The New York Times published a lengthy three paragraph correction.
Ana Cantu was a Human Guinea Pig in a Drug Trial for $4,800
"The study started out with 20 subjects…For about a week there were 14 subjects. Then they started dropping…Now, we’re down to 7."
NYT Promotes Alzheimer’s Expansion
New York Times reporter Gina Kolata, broadcasts medical hype on the front page of the paper much the way Judith Miller broadcast hype fed to her by Ahmed Chalabi and the Iraq war lobby.[1]
Columbia Brain Imaging Violations Condemned by Peers
"any slipshod work involving volunteers in clinical trials sends a shudder through the field," said Dr. Gary Small, a professor of psychiatry and biobehavioral sciences at UCLA
Will Another Blockbuster Drug Hit the Dust?
"The vote is an enormous blow to Avandia and GlaxoSmithKline. The vast majority of panel members voted either to withdraw the drug or to allow continued sales only if strict controls are added"
BMJ Demands Raw Data From Pharma Clinical Trials
The system has provided companies an opportunity to make spectacular profits from the widespread use of defective drugs and vaccines that have caused irreversible harm.
Flu Vaccine Fraud: WHO ‘Mr Flu’ Under Investigation For Gross Conflicts of Interest
One after another of the recently proclaimed Flu “pandemics” has turned out to be a fraudulent marketing hoax to promote flu vaccines.
Children Vaccinated Against Flu–> 3X Risk of Hospitalization
Evidence of harm has been linked to various vaccines challenging prevailing public recommendations.
Why big pharma mergers magnify failures_Haseltine_Atlantic
"Radical restructuring, not merger mania, is the need of our time." Dr. William Haseltine
Letter of Complaint to FDA Commissioner, 2007
Complaint about a surge of FDA administrative approvals for expanded use of highly toxic antipsychotic drugs for children. Approvals were determined by Dr. Thomas Laughren after secret deliberations–without disclosure of scientific data, without an advisory panel or open public discussion.
Cong. Hearings Loom: Pfizer, Halliburton
“No general counsel or CEO wants to have to explain to his board why the company's name is appearing on the front page of a news article in a scandal…"
NEJM- Caught Covering Up for National Kidney Foundation–an indudstry front group
Readers of the New England Journal of Medicine should be forewarned: The information in the pages of the NEJM is tainted by industry influence, its professional and scientific integrity are tainted.